UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5617) 5617
Book Chapter (55) 55
Newsletter (48) 48
Newspaper Article (15) 15
Magazine Article (13) 13
Web Resource (5) 5
Conference Proceeding (2) 2
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4867) 4867
science & technology (4086) 4086
life sciences & biomedicine (3956) 3956
male (3089) 3089
hepatitis c, chronic - drug therapy (3055) 3055
ribavirin - therapeutic use (3041) 3041
female (2969) 2969
antiviral agents - therapeutic use (2953) 2953
ribavirin (2776) 2776
middle aged (2731) 2731
drug therapy, combination (2639) 2639
hepatitis c (2379) 2379
adult (2338) 2338
antiviral agents - adverse effects (2228) 2228
ribavirin - adverse effects (2095) 2095
interferon-alpha - therapeutic use (2078) 2078
gastroenterology & hepatology (1907) 1907
treatment outcome (1895) 1895
interferon (1689) 1689
interferon-alpha - adverse effects (1601) 1601
ribavirin - administration & dosage (1561) 1561
hepatitis c virus (1560) 1560
recombinant proteins (1483) 1483
hepacivirus - genetics (1441) 1441
antiviral agents - administration & dosage (1420) 1420
polyethylene glycols - therapeutic use (1304) 1304
genotype (1296) 1296
aged (1276) 1276
interferon-alpha - administration & dosage (1071) 1071
hepatitis (1069) 1069
hepatitis c - drug therapy (1063) 1063
hepatitis c, chronic - virology (902) 902
polyethylene glycols - adverse effects (868) 868
health aspects (829) 829
hepacivirus - drug effects (817) 817
biological response modifiers (811) 811
infectious diseases (804) 804
drug therapy (776) 776
care and treatment (747) 747
recombinant proteins - therapeutic use (720) 720
viral load (671) 671
polyethylene glycols - administration & dosage (652) 652
hepatitis c, chronic - complications (623) 623
pharmacology & pharmacy (608) 608
antiviral agents (591) 591
rna, viral - blood (553) 553
virology (552) 552
retrospective studies (533) 533
chronic hepatitis c (510) 510
analysis (486) 486
infections (482) 482
genetic aspects (477) 477
liver (476) 476
prospective studies (468) 468
patients (465) 465
virus diseases (465) 465
abridged index medicus (458) 458
risk factors (454) 454
time factors (440) 440
young adult (439) 439
genotypes (437) 437
gastroenterology and hepatology (431) 431
recombinant proteins - adverse effects (417) 417
cirrhosis (416) 416
genotype & phenotype (415) 415
liver cirrhosis (390) 390
recurrence (388) 388
interferons - therapeutic use (386) 386
adolescent (382) 382
transplantation (369) 369
general & internal medicine (365) 365
viruses (364) 364
hepatology (357) 357
recombinant proteins - administration & dosage (354) 354
drug administration schedule (352) 352
medicine, general & internal (350) 350
liver transplantation (348) 348
research (343) 343
immunology (335) 335
hepatitis c - complications (331) 331
hepacivirus - isolation & purification (328) 328
polyethylene glycols (328) 328
hiv infections - complications (327) 327
pegylated interferon (327) 327
hcv (320) 320
clinical trials (307) 307
medicine & public health (302) 302
anemia (290) 290
hiv infections - drug therapy (287) 287
hepatitis c, chronic - genetics (286) 286
hepatitis c, chronic - diagnosis (278) 278
sustained virologic response (278) 278
dosage and administration (273) 273
follow-up studies (273) 273
dose-response relationship, drug (271) 271
liver diseases (267) 267
medical research (267) 267
oligopeptides - therapeutic use (265) 265
sofosbuvir (265) 265
gastroenterology (263) 263
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5429) 5429
Spanish (94) 94
French (64) 64
German (64) 64
Japanese (60) 60
Portuguese (50) 50
Polish (31) 31
Chinese (29) 29
Russian (19) 19
Korean (17) 17
Hungarian (13) 13
Croatian (5) 5
Czech (5) 5
Italian (5) 5
Serbian (5) 5
Danish (4) 4
Norwegian (3) 3
Dutch (2) 2
Swedish (2) 2
Arabic (1) 1
Finnish (1) 1
Hebrew (1) 1
Icelandic (1) 1
Romanian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of gastroenterology & hepatology, ISSN 0954-691X, 10/2018, Volume 30, Issue 10, pp. 1177 - 1186
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Background & Aims The interferon-free regimen of ABT-450 (a protease inhibitor), ritonavir, ombitasvir (an NS5A inhibitor), dasabuvir (a non-nucleoside... 
Gastroenterology and Hepatology | IFN | PEARL-II | Ribavirin-Free | Interferon-Free Therapy | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Anilides - therapeutic use | Puerto Rico | Hepatitis C - drug therapy | United States | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Biomarkers - blood | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Hepacivirus - growth & development | Aged | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical colleges | Care and treatment | Proteases | Ritonavir | Biological products industry | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 06/2015, Volume 15, Issue 6, pp. 645 - 653
Summary Background Compared with other countries, patients with chronic hepatitis C infection in Japan tend to be older, have more advanced liver disease, and... 
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Uridine Monophosphate - administration & dosage | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Benzimidazoles - administration & dosage | Time Factors | Ribavirin - administration & dosage | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Hepacivirus - isolation & purification | Administration, Oral | Japan | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Asian Continental Ancestry Group | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Liver | Dosage and administration | Product development | Drug therapy, Combination | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Hepatitis | Genotype & phenotype | Liver cancer | Heart attacks | Liver diseases | Human immunodeficiency virus--HIV | Hepatology | Response rates | Interferon | Infections | Drug dosages | Patients | Index Medicus
Journal Article
Pharmacotherapy, ISSN 0277-0008, 05/2020, Volume 40, Issue 5, pp. 416 - 437
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19)... 
dialysis | renal | antivirals | cytochrome P450 | infectious disease | liver | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pandemics | Alanine - adverse effects | Adrenal Cortex Hormones | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Thiazoles - administration & dosage | Hydroxychloroquine - adverse effects | Thiazoles - adverse effects | Alanine - analogs & derivatives | Alanine - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Ritonavir - adverse effects | Ribavirin - administration & dosage | Betacoronavirus | Antibodies, Monoclonal, Humanized - adverse effects | Ritonavir - administration & dosage | Immunomodulation | Azetidines - adverse effects | Chloroquine - adverse effects | Antiviral Agents - administration & dosage | Adenosine Monophosphate - adverse effects | Hydroxychloroquine - administration & dosage | Nelfinavir - adverse effects | Interferon-alpha - administration & dosage | Azetidines - administration & dosage | Ribavirin - adverse effects | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Antiviral Agents - adverse effects | Coronavirus Infections - therapy | Immunization, Passive | Lopinavir - administration & dosage | Sulfonamides - adverse effects | Chloroquine - administration & dosage | Interferon-alpha - adverse effects | Nelfinavir - administration & dosage | Drug Combinations | Lopinavir - adverse effects | Sulfonamides - administration & dosage | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Antiviral agents | Therapeutic applications | Clinical trials | Coronaviruses | Drug therapy | Patients | Index Medicus | Reviews of Therapeutics | Review of Therapeutics
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2013, Volume 368, Issue 1, pp. 34 - 44
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2011, Volume 141, Issue 6, pp. 2047 - 2055
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2014, Volume 370, Issue 21, pp. 1973 - 1982
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2014, Volume 370, Issue 17, pp. 1594 - 1603
Journal Article